首页> 外文期刊>Journal of neurology >Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy.
【24h】

Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy.

机译:坏死性肌病,类固醇反应性肌病的不正常表现。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the clinical features, muscle pathology and response to treatment in patients with a necrotising myopathy, without mononuclear cell infiltrates. BACKGROUND: Mononuclear cell infiltrates in the muscle biopsy specimen are the diagnostic hallmark of the immune-mediated idiopathic inflammatory myopathies (IIM). In patients with the typical clinical features of IIM, absence of these infiltrates in the muscle biopsy specimen casts doubt on the diagnosis and leads to uncertainty about therapeutical strategies. METHODS: A detailed description is given of the clinical, laboratory, and histopathological features of eight patients suspected of having an idiopathic inflammatory myopathy, in whom mononuclear cell infiltrates in their muscle biopsy specimens were lacking. RESULTS: Eight patients (five men, three women, age range 40-69 years) had severe, symmetrical proximal weakness with a subacute onset. There were no skin abnormalities suggesting dermatomyositis. Serum creatine kinase activity was more than 10 times elevated. Repeated muscle biopsy specimens, taken from a symptomatic muscle prior to immunosuppressive treatment showed widespread necrosis, regeneration, and atrophy of muscle fibres, but no mononuclear cell infiltrates. Known causes of necrotising myopathy were excluded. Three patients had a malignancy. Adequately dosed and sustained immunosuppressive treatment eventually resulted in normal or near normal muscle strength in seven patients. One patient showed marked improvement. CONCLUSION: Occasionally, patients who clinically present as an idiopathic inflammatory myopathy may lack mononuclear cell infiltrates in their muscle biopsy specimens. This subacute-onset progressive necrotising myopathy should not deter the clinician from timely and appropriate treatment as we consider this myopathy to be steroid-responsive with a possible immune-mediated pathogenesis.
机译:目的:评估没有单个核细胞浸润的坏死性肌病患者的临床特征,肌肉病理学和对治疗的反应。背景:肌肉活检标本中的单核细胞浸润是免疫介导的特发性炎症性肌病(IIM)的诊断标志。对于具有IIM典型临床特征的患者,肌肉活检标本中没有这些浸润物会给诊断带来疑问,并导致治疗策略的不确定性。方法:详细描述了八名怀疑患有特发性炎性肌病的患者的临床,实验室和组织病理学特征,他们的肌肉活检标本中缺乏单核细胞浸润。结果:8例患者(5例男性,3例女性,年龄在40-69岁之间)患有严重的对称性近端无力并伴有亚急性发作。没有皮肤异常提示皮肌炎。血清肌酸激酶活性提高了十倍以上。在免疫抑制治疗之前,从有症状的肌肉中进行的多次肌肉活检标本显示出广泛的坏死,再生和肌肉纤维萎缩,但没有单核细胞浸润。排除了坏死性肌病的已知原因。三名患者患有恶性肿瘤。适当的剂量和持续的免疫抑制治疗最终使7例患者的肌力正常或接近正常。一名患者表现出明显的改善。结论:临床表现为特发性炎性肌病的患者有时可能在其肌肉活检标本中缺乏单核细胞浸润。这种亚急性发作性进行性坏死性肌病不应阻止临床医生及时和适当的治疗,因为我们认为该肌病是类固醇反应性,可能是免疫介导的发病机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号